companydata.dkcompanydata.dk

STRAGEN NORDIC A/S: Financial statements 2025

CVR: 26717825

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

STRAGEN NORDIC A/S (CVR 26717825) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 4,246,350 and a net result of DKK 529,103 compared with DKK 2,665,035 the year before. That is a decrease of 50% compared with the year before. Equity in the 2025 report amounted to DKK 9,440,623. The solvency ratio was 48.1%. The company had 2 employees in the financial year.

Gross Profit
DKK 4,246,350
Profit/Loss
DKK 529,103
Equity
DKK 9,440,623
Total Assets
DKK 19,612,975
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-4.2M529K9.4M2
2024-8.5M2.7M8.9M0
2023-5.9M-463K6.2M0
2022-17.3M-3.3M6.7M0
2021-4.3M255K10M6

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is STRAGEN NORDIC A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

STRAGEN NORDIC A/S wins public contractOct 30, 2025

STRAGEN NORDIC A/S has won the tender "Amgros 2026 1.615.b" issued by Amgros I/S worth 48,195,968 DKK.

Anne Franch Nyquist-Hansen joins STRAGEN NORDIC A/S as adm. dir.Sep 30, 2025

As of September 30, 2025, Anne Franch Nyquist-Hansen is registered as adm. dir. of STRAGEN NORDIC A/S.

Ludovic Alonzi steps down as adm. dir. of STRAGEN NORDIC A/SSep 30, 2025

As of September 30, 2025, Ludovic Alonzi has stepped down as adm. dir. of STRAGEN NORDIC A/S.

Ludovic Alonzi joins the board of STRAGEN NORDIC A/SSep 19, 2025

As of September 19, 2025, Ludovic Alonzi has joined the board of directors of STRAGEN NORDIC A/S.

Didier Remi Dargent joins the board of STRAGEN NORDIC A/SSep 19, 2025

As of September 19, 2025, Didier Remi Dargent has joined the board of directors of STRAGEN NORDIC A/S.

Anne Franch Nyquist-Hansen leaves the board of STRAGEN NORDIC A/SSep 19, 2025

As of September 19, 2025, Anne Franch Nyquist-Hansen has left the board of directors of STRAGEN NORDIC A/S.

Ludovic Alonzi joins STRAGEN NORDIC A/S as adm. dir.Sep 19, 2025

As of September 19, 2025, Ludovic Alonzi is registered as adm. dir. of STRAGEN NORDIC A/S.

Didier Remi Dargent joins STRAGEN NORDIC A/S as suppleantSep 19, 2025

As of September 19, 2025, Didier Remi Dargent is registered as suppleant of STRAGEN NORDIC A/S.

Anne Franch Nyquist-Hansen steps down as adm. dir. of STRAGEN NORDIC A/SSep 19, 2025

As of September 19, 2025, Anne Franch Nyquist-Hansen has stepped down as adm. dir. of STRAGEN NORDIC A/S.

Ludovic Alonzi leaves the board of STRAGEN NORDIC A/SSep 18, 2025

As of September 18, 2025, Ludovic Alonzi has left the board of directors of STRAGEN NORDIC A/S.

About STRAGEN NORDIC A/S

STRAGEN NORDIC A/S is a Danish company of the type Aktieselskab based in Slangerup, founded in 2002. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Anne Franch Nyquist-Hansen and Didier Remi Dargent. The board consists of Didier Remi Dargent (chair), Jean-Yves Paul Etienne Desmottes and Ludovic Alonzi. The company is owned by Strategic Generics France. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 4,246,350 and a net result of DKK 529,103 compared with DKK 2,665,035 the year before. Equity in the 2025 report amounted to DKK 9,440,623.

Source: annual report 2025, Danish Business Authority